These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 35018242)

  • 61. Up-regulation of L Antigen Family Member 3 Associates With Aggressive Progression of Breast Cancer.
    Dong X; Lv S; Gu D; Zhang X; Ye Z
    Front Oncol; 2020; 10():553628. PubMed ID: 33552947
    [TBL] [Abstract][Full Text] [Related]  

  • 62. p53 but not bcl-2 immunostaining is predictive of poor clinical complete response to primary chemotherapy in breast cancer patients.
    Bottini A; Berruti A; Bersiga A; Brizzi MP; Brunelli A; Gorzegno G; DiMarco B; Aguggini S; Bolsi G; Cirillo F; Filippini L; Betri E; Bertoli G; Alquati P; Dogliotti L
    Clin Cancer Res; 2000 Jul; 6(7):2751-8. PubMed ID: 10914720
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Effect of COL4A1 Expression on the Survival of Neoadjuvant Chemotherapy Breast Cancer Patients.
    Wang SM; Chen PM; Sung YW; Huang WC; Huang HS; Chu PY
    J Oncol; 2020; 2020():5209695. PubMed ID: 32565804
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Mieap-induced accumulation of lysosomes within mitochondria (MALM) regulates gastric cancer cell invasion under hypoxia by suppressing reactive oxygen species accumulation.
    Okuyama K; Kitajima Y; Egawa N; Kitagawa H; Ito K; Aishima S; Yanagihara K; Tanaka T; Noshiro H
    Sci Rep; 2019 Feb; 9(1):2822. PubMed ID: 30808977
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Breast adipose tissue macrophages (BATMs) have a stronger correlation with breast cancer survival than breast tumor stroma macrophages (BTSMs).
    Lin L; Kuhn C; Ditsch N; Kolben T; Czogalla B; Beyer S; Trillsch F; Schmoeckel E; Mayr D; Mahner S; Jeschke U; Hester A
    Breast Cancer Res; 2021 Apr; 23(1):45. PubMed ID: 33849622
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Prognostic and biological significance of proliferation and HER2 expression in the luminal class of breast cancer.
    Jerjees DA; Alabdullah M; Green AR; Alshareeda A; Macmillan RD; Ellis IO; Rakha EA
    Breast Cancer Res Treat; 2014 Jun; 145(2):317-30. PubMed ID: 24744091
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A hedgehog pathway-dependent gene signature is associated with poor clinical outcomes in Luminal A breast cancer.
    Rudolph M; Sizemore ST; Lu Y; Teng KY; Basree MM; Reinbolt R; Timmers CD; Leone G; Ostrowski MC; Majumder S; Ramaswamy B
    Breast Cancer Res Treat; 2018 Jun; 169(3):457-467. PubMed ID: 29464534
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Elevated bile acid metabolism and microbiome are associated with suppressed cell proliferation and better survival in breast cancer.
    Wu R; Yu I; Tokumaru Y; Asaoka M; Oshi M; Yan L; Okuda S; Ishikawa T; Takabe K
    Am J Cancer Res; 2022; 12(11):5271-5285. PubMed ID: 36504906
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A Machine Learning Model to Predict the Triple Negative Breast Cancer Immune Subtype.
    Chen Z; Wang M; De Wilde RL; Feng R; Su M; Torres-de la Roche LA; Shi W
    Front Immunol; 2021; 12():749459. PubMed ID: 34603338
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Expression and clinicopathological significance of lipin-1 in human breast cancer and its association with p53 tumor suppressor gene.
    Dinarvand N; Khanahmad H; Hakimian SM; Sheikhi A; Rashidi B; Bakhtiari H; Pourfarzam M
    J Cell Physiol; 2020 Jul; 235(7-8):5835-5846. PubMed ID: 31970786
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A combined hypoxia and immune gene signature for predicting survival and risk stratification in triple-negative breast cancer.
    Yang X; Weng X; Yang Y; Zhang M; Xiu Y; Peng W; Liao X; Xu M; Sun Y; Liu X
    Aging (Albany NY); 2021 Aug; 13(15):19486-19509. PubMed ID: 34341184
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer.
    Cheang MC; Chia SK; Voduc D; Gao D; Leung S; Snider J; Watson M; Davies S; Bernard PS; Parker JS; Perou CM; Ellis MJ; Nielsen TO
    J Natl Cancer Inst; 2009 May; 101(10):736-50. PubMed ID: 19436038
    [TBL] [Abstract][Full Text] [Related]  

  • 73. GATA3 mutations define a unique subtype of luminal-like breast cancer with improved survival.
    Jiang YZ; Yu KD; Zuo WJ; Peng WT; Shao ZM
    Cancer; 2014 May; 120(9):1329-37. PubMed ID: 24477928
    [TBL] [Abstract][Full Text] [Related]  

  • 74. High TNFRSF12A level associated with MMP-9 overexpression is linked to poor prognosis in breast cancer: Gene set enrichment analysis and validation in large-scale cohorts.
    Yang J; Min KW; Kim DH; Son BK; Moon KM; Wi YC; Bang SS; Oh YH; Do SI; Chae SW; Oh S; Kim YH; Kwon MJ
    PLoS One; 2018; 13(8):e0202113. PubMed ID: 30142200
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Downregulated ZNF132 predicts unfavorable outcomes in breast Cancer via Hypermethylation modification.
    Liu Z; Liu J; Liu R; Xue M; Zhang W; Zhao X; Zhu J; Xia P
    BMC Cancer; 2021 Apr; 21(1):367. PubMed ID: 33827486
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Expression and methylation patterns partition luminal-A breast tumors into distinct prognostic subgroups.
    Netanely D; Avraham A; Ben-Baruch A; Evron E; Shamir R
    Breast Cancer Res; 2016 Jul; 18(1):74. PubMed ID: 27386846
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A Prognostic Gene Expression Signature in the Molecular Classification of Chemotherapy-naïve Urothelial Cancer is Predictive of Clinical Outcomes from Neoadjuvant Chemotherapy: A Phase 2 Trial of Dose-dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin with Bevacizumab in Urothelial Cancer.
    McConkey DJ; Choi W; Shen Y; Lee IL; Porten S; Matin SF; Kamat AM; Corn P; Millikan RE; Dinney C; Czerniak B; Siefker-Radtke AO
    Eur Urol; 2016 May; 69(5):855-62. PubMed ID: 26343003
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Tumor suppressor OTUD3 induces growth inhibition and apoptosis by directly deubiquitinating and stabilizing p53 in invasive breast carcinoma cells.
    Pu Q; Lv YR; Dong K; Geng WW; Gao HD
    BMC Cancer; 2020 Jun; 20(1):583. PubMed ID: 32571254
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Molecular and Clinical Characterization of CD80 Expression
    Zhang Q; Gao C; Shao J; Zhang S; Wang P; Wang Z
    Front Pharmacol; 2022; 13():869877. PubMed ID: 35814211
    [TBL] [Abstract][Full Text] [Related]  

  • 80. SPATA18 Expression Predicts Favorable Clinical Outcome in Colorectal Cancer.
    Sugimura-Nagata A; Koshino A; Nagao K; Nagano A; Komura M; Ueki A; Ebi M; Ogasawara N; Tsuzuki T; Kasai K; Takahashi S; Kasugai K; Inaguma S
    Int J Mol Sci; 2022 Mar; 23(5):. PubMed ID: 35269894
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.